Biphenyl amide p38 kinase inhibitors 1: Discovery and binding mode

被引：37

作者：

Angell, Richard M. ^{[1
]}

Bamborough, Paul ^{[1
]}

Cleasby, Anne ^{[1
]}

Cockerill, Stuart G. ^{[1
]}

Jones, Katherine L. ^{[1
]}

Mooney, Christopher J. ^{[1
]}

Somers, Donald O. ^{[1
]}

Walker, Ann L. ^{[1
]}

机构：

[1] GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 01期

关键词：

D O I：

10.1016/j.bmcl.2007.10.076

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The biphenyl amides (BPAs) are a novel series of p38 MAP kinase inhibitors. The discovery of the series through structure-based focused screening is described, and the binding mode of the compound is explained with reference to X-ray crystal structures. (C) 2007 Elsevier Ltd. All rights reserved.

引用

页码：318 / 323

页数：6

共 23 条

[21] P38 mitogen-activated protein kinase (MAPK) in rheumatoid arthritis [J].

Westra, J. ;

Limburg, P. C. .

MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2006, 6 (08) :867-874

[22] Crystal structure of p38 mitogen-activated protein kinase [J].

Wilson, KP ;

Fitzgibbon, MJ ;

Caron, PN ;

Griffith, JP ;

Chen, WY ;

McCaffrey, PG ;

Chambers, SP ;

Su, MSS .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (44) :27696-27700

[23] Structural comparison of p38 inhibitor-protein complexes: A review of recent p38 inhibitors having unique binding interactions [J].

Wrobleski, ST ;

Doweyko, AM .

CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (10) :1005-1016

← 1 2 3 →